It has been demonstrated that STING has low expression in pancreatic cancer [16], and STING is gradually defected in colon adenocarcinoma from stage II to the advanced stage, as assessed by immunohistochemical staining and RNA analysis [17]. This evidence concerns the gene STING1 and pancreatic neoplasm.